The big players are pumping hundreds of millions into Type one treatments and devices. Once LCT has confirmed results the US pharmas will all be circling for a piece of LCT, personally I believe that J&J will be the bidder once the results are out. Some snippits from today's papers show the interest and value this market offers:
"Medtronic's diabetes revenue jumped 18 percent in fiscal 2008, to just over $1.09 billion, helping to offset slowing sales in the company's core heart rhythm device business.
The diabetes business is focused on a number of technology advances, including an insulin pump that can automatically shut off insulin delivery if it detects blood sugar has fallen too low, a particular danger when a patient is sleeping. A pump with that safety feature is expected to gain approval for sale in Europe later this calendar year, O'Connell said. Both Insulet and J&J are working with DexCom to produce integrated systems that are expected to hit the market next year."
- Forums
- ASX - By Stock
- 1AI
- hmmmm. support broken
hmmmm. support broken, page-7
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $21.44K | 3.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 6215793 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 552894 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 6215793 | 0.006 |
11 | 4677719 | 0.005 |
6 | 3695009 | 0.004 |
3 | 4100000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 552894 | 2 |
0.008 | 2289083 | 11 |
0.009 | 1696637 | 10 |
0.010 | 4020149 | 6 |
0.011 | 1909287 | 5 |
Last trade - 15.38pm 02/10/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |